Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives

Journal of Medicinal Chemistry

Volumn 49, Issue 15, 2006, Pages 4790-4794

  Li, Yun Fei ^a   Wang, Gui Feng ^a   He, Pei Lan ^a   Huang, Wei Gang ^a   Zhu, Feng Hua ^a   Gao, He Yong ^a   Tang, Wei ^a   Luo, Yu ^a   Feng, Chun Lan ^a   Shi, Li Ping ^a   Ren, Yu Dan ^a   Lu, Wei ^b   Zuo, Jian Ping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 (5,6 DICHLORO 1 METHYL 1H BENZOIMIDAZOL 2 YL)ETHYL]ISOINDOLE 1,3 DIONE; 2 [2 [5,6 DICHLORO 1 (4 METHYLBENZYL) 1H BENZOIMIDAZOL 2 YL]ETHYL]ISOINDOLE 1,3 DIONE; ADEFOVIR DIPIVOXIL; BENZIMIDAZOLE DERIVATIVE; ENTECAVIR; LAMIVUDINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS B VIRUS; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BENZIMIDAZOLES; CELL LINE, TUMOR; DNA, VIRAL; HEPATITIS B VIRUS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33746741042     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060330f     Document Type: Article

References (12)

1. Mast, E. E.; Alter, M. J.; Margolis, H. S. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999, 17, 1730-1733.
2. Lavanchy, D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 2004, 11, 97-107.
3. Karayiannis, P. Hepatitis B virus: old, new and future approaches to antiviral treatment. J. Antimicrob. Chemother. 2003, 51, 761-785.
4. Hanazaki, K. Antiviral therapy for chronic hepatitis B: a review. Curr. Drug Targets Inflamm. Allergy 2004, 3, 63-70.
5. Misra, V. S.; Shan, P.; Saxena, V. K. Synthesis of some new benzimidazoles as antiamoebic agents. J. Indian Chem. Soc. 1982, 59, 1074-1076.
6. Zou, R.; Drach, J. C.; Townsend, L. B. Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-β-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections. J. Med. Chem. 1997, 40, 811-818.
7. Porcari, A. R.; Devivar R. V.; Kucera L. S.; Drach, J. C.; Townsend, L. B. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(β-D-ribofuranosyl)benzimidazole. J. Med. Chem. 1998, 41, 1252-1262.
8. Chapman, J. M., Jr.; Cocolas, G. H.; Hall, I. H. Hypolipidemic activity of phthalimide derivatives. 3. A comparison of phthalimide and 1,2-benzisothiazolin-3-one 1,1-dioxide derivatives to phthalimidine and 1,2-benzisothiazoline 1,1-dioxide congeners. J. Med. Chem. 1983, 26, 243-246.
9. Robertson, A.; Philp, D.; Spencer, N. Recognition-induced control of a Diels-Alder cycloaddition. Tetrahedron 1999, 55, 11365-11384.
10. Katritzky, A. R.; Yates, F. Phthaloylation of amino-azoles and amino-azines. J. Chem. Soc., Perkin Trans. 1 1976, 309-312.
11. Yang, D.; Fokas, D.; Li, J.; Yu, L.; Baldino, C. M. A versatile method for the synthesis of benzimidazoles from o-nitroanilines and aldehydes in one step via a reductive cyclization. Synthesis 2005, 47-56.
12. Fry, A. J.; Allukian, M.; Williams, A. D. Reduction of diaryl alkenes by hypophosphorous acid-iodine in acetic acid. Tetrahedron 2002, 58, 4411-4415.